Literature DB >> 19434204

The relative incidence of diabetes mellitus in ABO/Rhesus blood groups in South-Eastern Nigeria.

U A Okon1, A B Antai, E E Osim, S O Ita.   

Abstract

A total of 224 diabetics and 221 non-diabetics (control) were involved in this study, to determine the relative incidence of diabetes mellitus in ABO/Rhesus blood group. The current criteria for the diagnosis of diabetes mellitus were applied in differentiating the diabetics from the non-diabetics. Blood group, fasting blood sugar (FBS) and random blood sugar (RBG) were determined using standard methods. Type I, Type II and gestational diabetes mellitus were identified in this study. Biodata information were obtained during history taking and from subject hospital case note. The mean age of diabetics was 50.9 +/- 11.4 (SD) with age range of 24-72 years. Mean age for control was 49.21 +/- 9.25 with age range of 24-70 years. There were no significant differences between the mean ages of the two groups. Blood group O(-) and A(+) were significantly (P < 0.01) higher among the diabetics than non diabetics. Blood group O(+) was significantly (P < 0.01) lower in diabetics than in the control population. Blood group O(-) and A(+) therefore appears to be more susceptible to diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19434204     DOI: 10.4314/njps.v23i1-2.54897

Source DB:  PubMed          Journal:  Niger J Physiol Sci        ISSN: 0794-859X


  10 in total

1.  Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes.

Authors:  Lu Qi; Marilyn C Cornelis; Peter Kraft; Majken Jensen; Rob M van Dam; Qi Sun; Cynthia J Girman; Cathy C Laurie; Daniel B Mirel; David J Hunter; Eric Rimm; Frank B Hu
Journal:  Hum Mol Genet       Date:  2010-02-10       Impact factor: 6.150

Review 2.  Relationship between ABO blood group and pregnancy complications: a systematic literature analysis.

Authors:  Massimo Franchini; Carlo Mengoli; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2016-05-05       Impact factor: 3.443

3.  Is the Development of Gestational Diabetes Associated With the ABO Blood Group/Rhesus Phenotype?

Authors:  M Lemaitre; M Passet; L Ghesquière; C Martin; E Drumez; D Subtil; A Vambergue
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-22       Impact factor: 6.055

Review 4.  Relationships of ABO and Rhesus blood groups with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Solomon Getawa; Biruk Bayleyegn; Melak Aynalem; Yilkal Belete Worku; Tiruneh Adane
Journal:  J Int Med Res       Date:  2022-10       Impact factor: 1.573

5.  Association of ABO and Rh Blood Group Phenotypes with Type 2 Diabetes Mellitus at Felege Hiwot Comprehensive Referral Hospital Bahir Dar, Northwest Ethiopia.

Authors:  Biruk Legese; Molla Abebe; Alebachew Fasil
Journal:  Int J Chronic Dis       Date:  2020-11-05

6.  Type 2 diabetes mellitus and ABO/Rh blood groups.

Authors:  Forouzan Moinzadeh; Gholamreza Mahdieh Najafabady; Ali Toghiani
Journal:  J Res Med Sci       Date:  2014-04       Impact factor: 1.852

7.  Correlation of ABO Blood Group Phenotype and Rhesus Factor with Periodontal Disease: An Observational Study.

Authors:  Anju Gautam; Neelam Mittal; T B Singh; Ruchi Srivastava; Pushpendra Kumar Verma
Journal:  Contemp Clin Dent       Date:  2017 Apr-Jun

8.  The Correlation Between Blood Group Type and Diabetes Mellitus Type II: A Case-Control Observational Study From Pakistan.

Authors:  Simrah Sharjeel; Muhammad Wasi; Aliya Jafri; Fatima A Raza; Zara Tariq; Khizer Shamim; Kiran Abbas; Moiz Ahmed
Journal:  Cureus       Date:  2021-11-25

9.  Correlation between "ABO" blood group phenotypes and periodontal disease: Prevalence in south Kanara district, Karnataka state, India.

Authors:  Gurpur Prakash Pai; Mundoor Manjunath Dayakar; Mulki Shaila; Anitha Dayakar
Journal:  J Indian Soc Periodontol       Date:  2012-10

10.  The role of blood groups in the development of diabetes mellitus after gestational diabetes mellitus.

Authors:  Hatice Karagoz; Abdulsamet Erden; Ozerhan Ozer; Kubra Esmeray; Ali Cetinkaya; Deniz Avci; Samet Karahan; Mustafa Basak; Kadir Bulut; Hasan Mutlu; Yasin Simsek
Journal:  Ther Clin Risk Manag       Date:  2015-10-19       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.